James H. Gerlach - Concepedia

Author

James H. Gerlach

Also Known As

J Gerlach, J H Gerlach, J. Gerlach, J. H. GERLACH, J. H. Gerlach, J.H Gerlach, J.H. Gerlach, JAMES H. GERLACH, James Gerlach, James H Gerlach

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

Queen's University University of Colorado Denver University of Toronto Ontario Institute for Cancer Research Princess Margaret Cancer Centre

About

James H. Gerlach is an author at Queen's University specializing in medicine, cancer research, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	20	6.1K
2	Business	9	9	829
3	Management	9	9	829
4	Health Sciences	7	7	1.9K
5	Engineering	1	1	248

James H. Gerlach

Publications

7.4K

Citations

H-Index

Page 1

	Year	Citations
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line Susan P.C. Cole, Gabu Bhardwaj, James H. Gerlach, Science Gene AmplificationTumor MicroenvironmentOncogenic AgentMedicineTransporter Gene	1992	3K
Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance James H. Gerlach, Jane Endicott, Peter F. Juranka, Nature Medical MicrobiologyAntimicrobial Resistance GeneHealth SciencesBiochemistryMultidrug Resistance	1986	673
Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance. David R. Bell, James H. Gerlach, Norbert Kartner, Journal of Clinical Oncology GynecologyPathologyMultidrug ResistanceCancer BiologyTumor Biology	1985	408
Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. S E Mirski, James H. Gerlach, Susan P.C. Cole PubMed Tumor BiologyOncologyVinca AlkaloidsHealth SciencesMedicine	1987	352
Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. William S. Dalton, Brian G.M. Durie, David S. Alberts, PubMed Hematological MalignancyTumor BiologyOncologyHealth SciencesMedicine	1986	264
P-glycoprotein in human sarcoma: evidence for multidrug resistance. James H. Gerlach, David R. Bell, Constantine P. Karakousis, Journal of Clinical Oncology OncologyGlycosylationMedicineGlycobiologyImmunology	1987	255
An empirical analysis of open source software developers’ motivations and continuance intentions Chorng-Guang Wu, James H. Gerlach, Clifford E. Young Information & Management Software MaintenanceEmpirical AnalysisEngineeringOpen-source Software DevelopmentOpen-source Software	2007	248
Perceived risk and the consumer buying process: internet airline reservations Lawrence F. Cunningham, James H. Gerlach, Michael D. Harper, International Journal of Service Industry Management Customer SatisfactionOnline Customer BehaviorInternet Risk PremiumDigital MarketingInteractive Marketing	2005	242
Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels. Leah C. Young, Barbara G. Campling, Susan P.C. Cole, PubMed Mrp3 Protein LevelsCancer BiologyTumor BiologyDrug ResistanceOncology	2001	222
Membrane Topology of the Multidrug Resistance Protein (MRP) David R. Hipfner, Kurt C. Almquist, Elaine M. Leslie, Journal of Biological Chemistry	1997	216

Page 1